Search research articles
Contact Us
Filters
Showing results (41-50 of 162) with videos related to
Page
of 17
Sort By:
Oncology (Williston Park, N.Y.)
|
November 7, 1999
DNA topoisomerase I-targeting drugs as radiation sensitizers
A Y Chen, H Choy, M L Rothenberg
Journal of Cancer Research and Clinical Oncology
|
January 1, 1994
Gastric and esophageal cancers: perspectives from a U.S.-Japan meeting. Hawaii, February 6-7, 1993
M L Rothenberg, M Fukushima, C A Coltman
Stem Cells (Dayton, Ohio)
|
August 7, 1999
New drugs on the horizon: matrix metalloproteinase inhibitors
M L Rothenberg, A R Nelson, K R Hande
Nature Reviews. Cancer
|
April 3, 2003
Improving the evaluation of new cancer treatments: challenges and opportunities
Mace L Rothenberg, David P Carbone, David H Johnson
Gastroenterology
|
May 12, 2005
Treatment for pancreatic cancer: current therapy and continued progress
A Craig Lockhart, Mace L Rothenberg, Jordan D Berlin
Journal of Cancer Research and Clinical Oncology
|
January 1, 1997
Bone and soft tissue sarcomas: summary of the Third United States/Japan Clinical Trials Summit (Seattle, Washington)
A Uchida, M Fukushima, M L Rothenberg, et al.
Diabetes
|
July 1, 1995
Glucose-induced insulin receptor tyrosine phosphorylation in insulin-secreting beta-cells
P L Rothenberg, L D Willison, J Simon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 1, 2000
Matrix metalloproteinases: biologic activity and clinical implications
A R Nelson, B Fingleton, M L Rothenberg, et al.
The Oncologist
|
February 15, 2005
Cancer pharmacogenomics: powerful tools in cancer chemotherapy and drug development
Wooin Lee, A Craig Lockhart, Richard B Kim, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 1, 2016
Pragmatic randomized clinical trials: a proposal to enhance evaluation of new cancer therapies with early signs of exceptional activity
M Koehler, E T Donnelly, D Kalanovic, et al.
Page
of 17
Search research articles
Search
Showing results (41-50 of 162) with videos related to
Sort By:
Page
of 17
Oncology (Williston Park, N.Y.)
|
November 7, 1999
DNA topoisomerase I-targeting drugs as radiation sensitizers
A Y Chen, H Choy, M L Rothenberg
Journal of Cancer Research and Clinical Oncology
|
January 1, 1994
Gastric and esophageal cancers: perspectives from a U.S.-Japan meeting. Hawaii, February 6-7, 1993
M L Rothenberg, M Fukushima, C A Coltman
Stem Cells (Dayton, Ohio)
|
August 7, 1999
New drugs on the horizon: matrix metalloproteinase inhibitors
M L Rothenberg, A R Nelson, K R Hande
Nature Reviews. Cancer
|
April 3, 2003
Improving the evaluation of new cancer treatments: challenges and opportunities
Mace L Rothenberg, David P Carbone, David H Johnson
Gastroenterology
|
May 12, 2005
Treatment for pancreatic cancer: current therapy and continued progress
A Craig Lockhart, Mace L Rothenberg, Jordan D Berlin
Journal of Cancer Research and Clinical Oncology
|
January 1, 1997
Bone and soft tissue sarcomas: summary of the Third United States/Japan Clinical Trials Summit (Seattle, Washington)
A Uchida, M Fukushima, M L Rothenberg, et al.
Diabetes
|
July 1, 1995
Glucose-induced insulin receptor tyrosine phosphorylation in insulin-secreting beta-cells
P L Rothenberg, L D Willison, J Simon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 1, 2000
Matrix metalloproteinases: biologic activity and clinical implications
A R Nelson, B Fingleton, M L Rothenberg, et al.
The Oncologist
|
February 15, 2005
Cancer pharmacogenomics: powerful tools in cancer chemotherapy and drug development
Wooin Lee, A Craig Lockhart, Richard B Kim, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 1, 2016
Pragmatic randomized clinical trials: a proposal to enhance evaluation of new cancer therapies with early signs of exceptional activity
M Koehler, E T Donnelly, D Kalanovic, et al.
Page
of 17